Dipraglurant receives orphan drug designation from the FDA for levodopa-induced dyskinesia associated with Parkinson's disease

Addex Therapeutics, a leading company pioneering allosteric modulation-based drug discovery and development, announced today that the US Food and Drug Administration (FDA) has granted orphan drug...
Source: Parkinson's Disease News From Medical News Today - Category: Neurology Tags: Parkinson's Disease Source Type: news